Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor
International Braz J Urol, 09/01/09
Pouessel D et al. – The frequency of fatal ICH in RCC patients with brain metastases treated with tyrosine kinase inhibitors targeting the VEGFR seems high. Prospective clinical trials will be necessary for assessing the true incidence and predictive factors related to this toxicity.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09
A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia
Clinical Journal of the American Society of Nephrology, 11/05/09
Anemia and Erythrocytosis After Kidney Transplantation: A 5-Year Graft Function and Survival Analysis
Transplantation Proceedings, 11/11/09
Today in Vascular...keeping you current
Receive free subspecialty "5-minute updates" via email
Results of surgical treatment for renovascular hypertension in children: 30 year single centre experience
Nephrology Dialysis Transplantation, 10/30/09
Renal artery stenosis: pathophysiology and treatment
Expert Review of Cardiovascular Therapy , 11/18/09
Pre-diabetes and arterial stiffness in uraemic patients
Nephrology Dialysis Transplantation, 10/30/09
Article Search
Sponsor


See Latest Articles


